Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

5.450 -1.040 (-16.02%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	245,156
Open	6.500
Bid (Size)	5.580 (3,000)
Ask (Size)	8.790 (100)
Prev. Close	6.490
Today's Range	5.350 - 6.793
52wk Range	3.200 - 12.99
Shares Outstanding	19,474,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts

May 05, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics

April 18, 2026

Via ACCESS Newswire

Performance

YTD	-38.6%	-38.6%
1 Month	+1.5%	+1.5%
3 Month	-44.2%	-44.2%
6 Month	-46.1%	-46.1%
1 Year	-17.4%	-17.4%

More News

NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results

April 14, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Provides Business Update and Reports Q4 2025 Financial Results

April 01, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints David Choi as Chief Accounting Officer

March 13, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)

March 12, 2026

Via Newsfile

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET

March 04, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity

February 27, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America

February 21, 2026

Via ACCESS Newswire

New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)

February 14, 2026

Via ACCESS Newswire

New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America

February 07, 2026

Via ACCESS Newswire

New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America

January 31, 2026

Via ACCESS Newswire

NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management

January 30, 2026

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)

January 09, 2026

Via Newsfile

New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators

January 03, 2026

Via ACCESS Newswire

New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television

December 27, 2025

Via ACCESS Newswire

New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)

December 20, 2025

Via ACCESS Newswire

NeOnc Technologies Reports Updated Clinical Results

December 15, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

December 01, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

November 14, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)

November 13, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Reports Updated Clinical Results

November 12, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

November 07, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth

November 04, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment

October 28, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?

Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.

What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?

NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?

The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market

What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?

The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 5.450

When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?

The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 05/08/26 04:00 PM ET

What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?

The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 106.13M

How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?

NeOnc Technologies Holdings, Inc. - Common Stock has 106M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.